Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05054959

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Induction Versus Consolidation Chemotherapy in Total Neoadjuvant Therapy of Localy Advanced Rectal Cancer With High Risk of Recurrence (ICONA Study)

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Institute of Oncology Ljubljana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to identify the most promising sequence of modalities in total neoadjuvant treatment of localy advanced rectal cancer with high risk of recurrence

Detailed description

International recommendations for the treatment of LARC with a high risk of disease recurrence are inconsistent, regarding TNT. In Germain randomised study more pCR were achieved with consolidation chemotherapy. We will compare our standard approach (induction plus consolidation CT) with consolidation CT.

Conditions

Interventions

TypeNameDescription
OTHERconsolidation chemotherapy6 cycles CAPOX after chemoradiotherapy
OTHERinduction chemotherapy4 cycles CAPOX before and 2 cycles CAPOX after chemoradiotherapy

Timeline

Start date
2021-06-24
Primary completion
2022-12-31
Completion
2027-12-31
First posted
2021-09-23
Last updated
2021-09-23

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT05054959. Inclusion in this directory is not an endorsement.